Ivermectin

COVID-19

Sylvester Researcher Finds FDA-Approved Antiviral Drug Can Be Delivered Via Nanoparticle for COVID-19

A Sylvester Comprehensive Cancer Center researcher at the University of Miami Miller School of Medicine has found that an orally administered nanoparticle can deliver the FDA-approved drug Ivermectin to suppress the COVID-19 virus. “Our…

Dec. 02 2020 | Share

Researchers Report COVID-19 Found in Penile Tissue Could Contribute to Erectile Dysfunction

COVID-19 Remembrance Ceremony Reflects Both Painful Losses and Renewed Hope for the Future

Study Shows Pfizer and Moderna are Effective in Preventing COVID-19 Among Health Care and Frontline Workers

New Miller School Study Highlights How Obesity Hinders COVID-19 Immune System Response

New Center Expands Services to Parkinson’s Disease Community, Targeting Underserved Spanish-Speaking Population

Diabetes Research Institute Launches Trial of Novel Investigational Treatment for Type 1 Diabetes

Miller School Study Looks at Patient Frailty and Endoscopy Risks

Programs Benefiting Sylvester Cancer Survivors Adapt and Thrive Throughout Pandemic

Dr. Glen Barber Elected a Fellow of the Royal Society

First-Year M.D./M.P.H. Student Receives External Grant for Study of Sexual Dysfunction in Pelvic Cancer

NIH Grant Supports Innovative Multifaceted Heart Study

New $9.8 Million NCI Grant Awarded to Study Hispanic/Latino Cancer Survivorship

Four UM Faculty Inducted into Academy of Science, Engineering and Medicine of Florida

New Program to Train Next Generation of HIV Behavioral Scientists

First-Year M.D./M.P.H. Student Receives External Grant for Study of Sexual Dysfunction in Pelvic Cancer

Castaways Against Cancer Paddle Toward a Cure

Ivermectin

Sylvester Researcher Finds FDA-Approved Antiviral Drug Can Be Delivered Via Nanoparticle for COVID-19